台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效

智基

(6294)
可現股當沖
  • 股價
    118.5
  • 漲跌
    ▲0.5
  • 漲幅
    +0.42%
  • 成交量
    90
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智基 (6294)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/19 ~ 2024/05/03     後一日»

券商獲利排行 - 2024/04/19 ~ 2024/05/03

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  1.01%53.2-0.153.343451117.3117.3117.2118.5
  0.91%32-0.932.827303117.3117.3117118.5
  1.11%28.517.910.642217116.8116.4117.4118.5
  1.41%2302313140116.9116.9116118.5
  0.98%19.5-2.722.214173116.8116.9116118.5
  0.52%16-0.616.624262117.8117.8117.5118.5
  1.66%15.5015.5880116.6116.60118.5
  1.45%13.51.911.6682116.8116.6117.5118.5
  2.16%12.5012.55501161160118.5
  0.89%10.5010.510100117.5117.50118.5
  0.99%10.58.91.6198117.4116.9118118.5
  0.35%9-3.612.615227117.5117.7117.1118.5
  2.60%909330115.5115.50118.5
  2.60%909330115.5115.50118.5
  0.80%7.507.5880117.6117.60118.5
  1.28%7.507.55501171170118.5
  1.11%6.56.50055117.5116.8118.1118.5
  1.39%6.506.5440116.9116.90118.5
  2.80%6.506.5120115.4115.3117.5118.5
  0.42%606121201181180118.5
  0.59%5.5-0.25.7781117.7117.7117.5118.5
  0.85%505550117.5117.50118.5
  0.42%505-9010119116119118.5
  0.85%505450117.5117.5118.5118.5
  2.16%5052201161160118.5
  0.74%3.503.5340117.6117.6117.9118.5
  3.04%3.503.51101151150118.5
  1.50%3.503.5220116.8116.80118.5
  0.49%3.503.5560117.9117.9117118.5
  2.60%303110115.5115.50118.5
  0.50%312-315118.8118119118.5
  2.56%330011117115.5118.5118.5
  1.28%3032201171170118.5
  1.28%3032201171170118.5
  2.49%2.92.90011117.5116.1119118.5
  0.77%2.72.70033116.8116.3117.2118.5
  0.19%2.502.511110118.3118.30118.5
  2.16%2.502.51101161160118.5
  2.16%2.502.51101161160118.5
  2.16%2.502.51101161160118.5
  0.71%2.50.52131117.6117.5118118.5
  2.13%2.52.50011117.3116118.5118.5
  2.14%2.52.50011116.8115.5118118.5
  2.15%2.502.5010116.1116118118.5
  2.16%2.502.51101161160118.5
  2.16%2.502.51101161160118.5
  1.06%2.502.5121116116116118.5
  1.81%2.102.1110116.4116.40118.5
  0.59%2.102.1330117.8117.80118.5
  1.72%202110116.5116.50118.5

券商虧損排行 - 2024/04/19 ~ 2024/05/03

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -0.51%-33.7-36.22.465650117.8118.1117.4118.5
  -1.04%-25.51.6-27.1-20121117.1115.5117.1118.5
  -0.77%-20-5-15-15722117.7118.2117.5118.5
  -2.69%-15.50-15.5-505115.40115.4118.5
  -2.60%-150-15-505115.50115.5118.5
  -2.60%-150-15-505115.50115.5118.5
  -1.86%-130-13-606116.30116.3118.5
  -0.85%-13-4.9-8.1-5813117.1117.5116.9118.5
  -0.53%-12.5-5.1-7.4-81220117.7118117.6118.5
  -0.53%-12.5-14.41.922018117.2117.6116.8118.5
  -1.14%-10.7-0.2-10.5-618117117.2117118.5
  -2.27%-10.50-10.5-404115.90115.9118.5
  -0.74%-10.50.1-10.5-10112117.5117.5117.5118.5
  -2.60%-90-9-303115.50115.5118.5
  -1.46%-8.50-8.5-405116.8118116.8118.5
  -0.43%-7.50-7.5-14015118118118118.5
  -0.85%-70-7-707117.50117.5118.5
  -2.59%-60-6-102115.6117.5115.5118.5
  -2.56%-5.90-5.9-202115.50115.5118.5
  -1.66%-5.8-1.1-4.7-113116.5117.3116.2118.5
  -2.47%-5.70-5.7-202115.7117115.6118.5
  -1.57%-5.5-1.5-4-213116.9118116.5118.5
  -0.78%-5.5-0.5-5-516117.6118117.5118.5
  -0.30%-5-6.51.531411117.7118117.4118.5
  -2.16%-50-5-2021160116118.5
  -1.07%-5-0.1-4.9-314116.9117116.9118.5
  -2.16%-50-5-2021160116118.5
  -1.07%-5-0.9-4.1-314117.3118117.1118.5
  -1.28%-4.50-4.5-3031170117118.5
  -1.72%-4-40022116.5117.5115.5118.5
  -0.85%-40-4-404117.50117.5118.5
  -0.32%-3.10-3.1-808118.1118118.1118.5
  -0.86%-30.3-3.3-213116.8116.5116.8118.5
  -1.28%-30-3-102117118117118.5
  -1.28%-30-3-2021170117118.5
  -1.28%-30-3-2021170117118.5
  -0.85%-30-3-303117.50117.5118.5
  -2.60%-30-3-101115.50115.5118.5
  -0.85%-30-3-303117.50117.5118.5
  -2.60%-30-3-101115.50115.5118.5
  -2.59%-30-3001115.6118115.5118.5
  -0.21%-2.7-2.7001111117.5117.6117.4118.5
  -0.53%-2.50-2.5-404117.90117.9118.5
  -2.16%-2.50-2.5-1011160116118.5
  -2.16%-2.50-2.5-1011160116118.5
  -2.16%-2.50-2.5-1011160116118.5
  -2.16%-2.50-2.5-1011160116118.5
  -2.16%-2.50-2.5-1011160116118.5
  -2.15%-2.50-2.5001116.1118.3116118.5
  -1.06%-2.5-2.50022117.4118116.8118.5
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音